Article Information
History
- July 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Georgi Apriamashvili1,5,
- David W. Vredevoogd1,5,
- Oscar Krijgsman1,6,
- Onno B. Bleijerveld2,4,6,
- Maarten A. Ligtenberg1,
- Beaunelle de Bruijn1,
- Julia Boshuizen1,
- Daniela D’Empaire Altimari1,
- Nils L. Visser1,
- James D. Londino3,
- Maarten Altelaar2,4 and
- Daniel S. Peeper1,*
- 1Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
- 2Proteomics Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
- 3Division of Pulmonary, Critical Care and Sleep Medicine, The Ohio State University Wexner Medical Center, 410W 10th Avenue, Columbus, Ohio, USA
- 4Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, and Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands
- ↵*Correspondence to: Daniel S. Peeper, Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands, E-mail: d.peeper{at}nki.nl, Tel.: +31 20 512 2002